Arcutis Biotherapeutics Inc (ARQT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 44,755 | 30,858 | 49,569 | 13,526 | 38,109 |
| Cost of Goods | 5,503 | 3,464 | 3,256 | 2,246 | 1,182 |
| Gross Profit | 39,252 | 27,394 | 46,313 | 11,280 | 36,927 |
| Operating Expenses | 78,821 | 77,935 | 78,191 | 72,695 | 74,013 |
| Operating Income | -39,066 | -50,077 | -31,622 | -61,169 | -36,904 |
| Interest Expense | 6,653 | 7,484 | 7,480 | 7,762 | 7,559 |
| Other Income | 4,182 | 5,229 | 4,044 | 2,737 | 2,721 |
| Pre-tax Income | -41,537 | -52,332 | -35,058 | -66,194 | -41,742 |
| Income Tax | N/A | N/A | 324 | 90 | 3,023 |
| Net Income Continuous | -41,537 | -52,332 | -35,382 | -66,284 | -44,765 |
| Net Income | $-41,537 | $-52,332 | $-35,382 | $-66,284 | $-44,765 |
| EPS Basic Total Ops | -0.33 | -0.42 | -0.32 | -0.58 | -0.73 |
| EPS Basic Continuous Ops | -0.33 | -0.42 | -0.32 | -0.59 | -0.73 |
| EPS Diluted Total Ops | -0.33 | -0.42 | -0.32 | -0.58 | -0.73 |
| EPS Diluted Continuous Ops | -0.33 | -0.42 | -0.32 | -0.59 | -0.73 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.42 | -0.32 | -0.72 | -0.73 |
| EBITDA(a) | $-39,326 | $-52,114 | $-32,989 | $-62,256 | $-38,049 |